MedTrace Logo

Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer

NCT04864431 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-06-22

No results posted yet for this study

Summary

Several ex vivo, in vitro, and observational studies on various type of cancer shown positive effect of vitamin D. Vitamin D has widely known as immunomodulator property in various diseases. However, it remains limited studies on immunity and cachexia in cancer, particularly in ovarian cancer. This study will investigate the effect of vitamin D in immune response during chemotherapy among epithelial ovarian cancer patients who have a low level of vitamin D and cachexia

Conditions

  • Epithelial Ovarian Cancer

Interventions

DIETARY_SUPPLEMENT

Vitamin D

Vitamin D capsules: each capsule contain 2 tablets of vitamin D 1000 IU. One capsule will be taken on day 1 through 180

OTHER

Placebo

Placebo capsule: Each capsule contain saccharum lactis. One capsule will be taken on day 1 through 180

Sponsors & Collaborators

  • Dharmais National Cancer Center Hospital

    collaborator OTHER_GOV

  • Indonesia University

    lead OTHER

Principal Investigators

  • Nurul Ratna Mutu Manikam, MD, MSc · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-12
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04864431 on ClinicalTrials.gov